While targeting nestin holds therapeutic promise for pulmonary fibrosis, its expression in a broad spectrum of progenitor and structural cells—including myofibroblasts, pericytes, and smooth muscle cells—warrants careful consideration of potential systemic and off‐target effects. Here, NES is linked to pulmonary fibrosis.